NetScientific (NSCI) is a transatlantic life sciences/healthcare, sustainability and technology investment and commercialisation group that seeks to realise shareholder value through managed exists. Our analysis shows that ca.80% of the core portfolio's value lies within PDS Biotech (NSDAQ: PDSB), ProAxsis and Glycotest, with a portfolio of minority investments and carried interests providing significant optionality to investors. ProAxsis, now a 100% subsidiary, is generating commercial returns, ....
25 May 2021
NetScientific (NSCI) - Re-initiation of coverage and introduction of forecasts
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
NetScientific (NSCI) - Re-initiation of coverage and introduction of forecasts
NetScientific plc (NSCI:LON) | 63.0 0 0.0% | Mkt Cap: 15.1m
- Published:
25 May 2021 -
Author:
John Cummins | Matthew Davis -
Pages:
24
NetScientific (NSCI) is a transatlantic life sciences/healthcare, sustainability and technology investment and commercialisation group that seeks to realise shareholder value through managed exists. Our analysis shows that ca.80% of the core portfolio's value lies within PDS Biotech (NSDAQ: PDSB), ProAxsis and Glycotest, with a portfolio of minority investments and carried interests providing significant optionality to investors. ProAxsis, now a 100% subsidiary, is generating commercial returns, ....